Medications for Enlarged Prostate (BPH)
These are drugs that have been approved by the US Food and Drug Administration (FDA), meaning they have been determined to be safe and effective for use in Enlarged Prostate (BPH).
Found 7 Approved Drugs for Enlarged Prostate (BPH)
Tamsulosin
Brand Names
Flomax, Dutasteride
Tamsulosin
Brand Names
Flomax, Dutasteride
Form: Capsule
Method of administration: Oral
FDA approval date: September 12, 1997
Classification: alpha-Adrenergic Blocker
Tamsulosin hydrochloride capsules are indicated for the treatment of the signs and symptoms of benign prostatic hyperplasia (BPH). Tamsulosin hydrochloride capsules are not indicated for the treatment of hypertension. Tamsulosin hydrochloride is an alpha 1 adrenoceptor antagonist indicated for treatment of the signs and symptoms of benign prostatic hyperplasia ( 1 ), Tamsulosin hydrochloride capsules are not indicated for the treatment of hypertension ( 1 )
Cardura
Generic Name
Doxazosin
Cardura
Generic Name
Doxazosin
Form: Tablet
Method of administration: Oral
FDA approval date: October 18, 2000
Classification: alpha-Adrenergic Blocker
Doxazosin tablets are an alpha 1 adrenergic antagonist indicated for: 3. Signs and symptoms of Benign Prostatic Hyperplasia (BPH) 4. Treatment of HypertensionTreatment of Hypertension.
Avodart
Generic Name
Dutasteride
Avodart
Generic Name
Dutasteride
Form: Capsule
Method of administration: Oral
FDA approval date: November 02, 2015
Classification: 5-alpha Reductase Inhibitor
Dutasteride is a 5 alpha-reductase inhibitor indicated for the treatment of symptomatic benign prostatic hyperplasia (BPH) in men with an enlarged prostate to.
Tezruly
Generic Name
Terazosin
Tezruly
Generic Name
Terazosin
Form: Capsule, Solution
Method of administration: Oral
FDA approval date: March 30, 1998
Classification: alpha-Adrenergic Blocker
Terazosin capsules, USP are indicated for the treatment of symptomatic benign prostatic hyperplasia (BPH). There is a rapid response, with approximately 70% of patients experiencing an increase in urinary flow and improvement in symptoms of BPH when treated with terazosin capsules, USP. The long-term effects of terazosin capsules, USP on the incidence of surgery, acute urinary obstruction or other complications of BPH are yet to be determined. Terazosin capsules, USP are also indicated for the treatment of hypertension. Terazosin capsules, USP can be used alone or in combination with other antihypertensive agents such as diuretics or beta-adrenergic blocking agents.
Tadalafil
Brand Names
Opsynvi, Tadliq, Adcirca, Cialis, ALYQ
Tadalafil
Brand Names
Opsynvi, Tadliq, Adcirca, Cialis, ALYQ
Form: Tablet, Suspension
Method of administration: Oral
FDA approval date: November 26, 2003
Classification: Phosphodiesterase 5 Inhibitor
CIALIS ® is a phosphodiesterase 5 (PDE5) inhibitor indicated for the treatment of: erectile dysfunction (ED).
Showing 1-5 of 7
Not sure about your diagnosis?
Check Your Symptoms
Tired of the same old research?
Check Latest Advances